| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |